Pertussis Vaccination Failure in the New Zealand Pediatric Population: Study Protocol
Pertussis vaccines have been effective at reducing pertussis-associated morbidity and mortality. However, they have a complex array of limitations, particularly associated with the duration of protection against clinical disease and imperfect immunity (carriage and transmission). Little is known abo...
Main Authors: | Hannah Chisholm, Anna Howe, Emma Best, Helen Petousis-Harris |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-07-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/7/3/65 |
Similar Items
-
Pertussis vaccines and the role of <I>Bordetella pertussis</I> lipooligosaccharide in the immune response to pertussis infection and vaccination
by: I. A. Alekseeva, et al.
Published: (2021-03-01) -
Pertussis Prevention: Reasons for Resurgence, and Differences in the Current Acellular Pertussis Vaccines
by: Susanna Esposito, et al.
Published: (2019-07-01) -
Pertussis Toxin: A Key Component in Pertussis Vaccines?
by: Kelsey A. Gregg, et al.
Published: (2019-09-01) -
Antibody avidity to pertussis toxin after acellular pertussis vaccination and infection
by: Aapo Knuutila, et al.
Published: (2023-12-01) -
Bordetella pertussis Strain Lacking Pertactin and Pertussis Toxin
by: Margaret M. Williams, et al.
Published: (2016-02-01)